Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Awards
Help
Project Grant W81XWH2210225
Award Date
5/1/22
Completion Date
4/30/24
Dollars Obligated
$3.5M
Overview
Activity
5
Transactions
5
Subawards
Federal Agency
Defense Health Agency
Awardee
Aktivax, Inc. (T1XHPCDJ4NT6)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westminster, CO 80021, USA
Description
Update #1
TRANEXAMIC ACID AUTOINJECTOR FOR IMMEDIATE TREATMENT OF HEMORRHAGE ON BATTLEFIELD
Posted 4/25/22, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
Not listed
THIS MODIFICATION APPROVES AND INCORPORATES BY REFERENCE, THE REVISED STATEMENT OF WORK (SOW) DATED 14 DECEMBER 2023. ALL OTHER TERMS & CONDITIONS REMAIN UNCHANGED.
$0
2/20/24
Not listed
THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE A PI CHANGE TO DR. SLAVEK SLONIOWSKI. SEE SUMMARY OF CHANGES P00003 FOR IMPORTANT ADMINISTRATIVE CHANGES TO THIS AWARD. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.
$1.8m
12/26/23
Not listed
TRANEXAMIC ACID AUTOINJECTOR FOR IMMEDIATE TREATMENT OF HEMORRHAGE ON BATTLEFIELD EXTEND THE PERIOD OF PERFORMANCE, ADD FUNDING, INCORPORATE REVISED BUDGET, AND STATEMENT OF WORK 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022. THIS MODIFICATION REFLECTS CHANGES CONSISTENT WITH THE TRANSFER TO DHA. 2. DIVISION II HAS BEEN UPDATED TO SUPERSEDE DIVISION III, PART 2, SECTION C, 2.B. ELECTRONIC PAYMENT INSTRUCTIONS
$500.0k
4/3/23
Not listed
THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0001, IN THE AMOUNT OF $109,262.75 TO FULLY FUND THE CLIN. THE TOTAL FUNDED AMOUNT OF THE AWARD IS INCREASED BY $109,262.75 FROM $1,156,299.25 TO $1,265,562.001
$109.3k
9/26/22
Not listed
TRANEXAMIC ACID AUTOINJECTOR FOR IMMEDIATE TREATMENT OF HEMORRHAGE ON BATTLEFIELD
$1.2m
4/25/22